THE Federal Court of Australia
has ordered that the specification
of Les Laboratoires Servier’s patent
titled ‘New salt of perindopril
and pharmaceutical compositions
containing it’ did not comply with
the Patents Act because it failed to
disclose the best method known of
performing the invention.
In the case between the applicant
Apotex Pty Ltd and the respondents
Les Laboratoires Servier and
Servier Laboratories (Aust) Pty
Ltd, the Honourable Justice Rares
also ruled that Apotex’s claim for
relief in its amended application be
dismissed but that the question as
to whether any amendment to the
patent ought to be granted, among
others, would be reserved for
consideration.
CLICK HERE for more.The above article was sent to subscribers in Pharmacy Daily's issue from 23 Jul 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Jul 14
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.